![]() |
|
| médicaments Actualité MedSanté | Sommaire |
|
|
effet secondaire medicaments
|
|
Characteristics
of included studies
|
|||||||
|
Studies
|
Design
|
Data
source |
NSAID
exposure |
Study
outcome |
AMI
events (n) |
No
AMI events (n) |
|
|
Nested
case control GPRD (UK) |
Current
NSAID users: |
First
hospitalized |
Diclofenac
= 213 |
Diclofenac
= 679 |
MI
risk factors (smoking, |
||
|
|
|
patients
(age 50–84 |
AMI
or death due to |
Ibuprofen
= 155 |
Ibuprofen
= 575 |
diabetes,
hypertension, |
|
|
|
|
years)
whose most |
CHD
|
Naproxen
= 49 |
Naproxen
= 206 |
hyperlipidemia,
BMI, RA, |
|
|
|
|
recent
prescription |
|
|
|
OA,
anemia, CHD, CVD), |
|
|
|
|
lasted
until the index |
|
|
|
age,
sex, calendar year, |
|
|
|
|
date
or ended in the 30 |
|
|
|
alcohol
intake, and use of |
|
|
|
|
days
before the index |
|
|
|
steroids,
aspirin, |
|
|
|
|
date
|
|
|
|
anticoagulants,
paracetamol, and NSAIDs |
|
|
Nested
case control GPRD (UK) |
Current
NSAID users: |
First
hospitalized |
Nonaspirin
NSAIDs |
Nonaspirin
NSAIDs |
Age,
use of HRT, smoking, |
||
|
|
|
menopausal
women |
AMI
|
=
40 |
=
143 |
hypertension,
diabetes, |
|
|
|
|
(age
50–74 years) who |
|
|
|
obesity,
surgical |
|
|
|
|
had
a prescription for |
|
|
|
menopause,
family history |
|
|
|
|
NSAIDs
before the index |
|
|
|
of
CHD, and predefined |
|
|
|
|
date
|
|
|
|
co-morbidity
|
|
|
Nested
case control Managed care |
Current
NSAID users: |
Hospitalized
AMI, |
Ibuprofen
= 670 |
Ibuprofen
= 2573 |
Sex,
age, geographic |
||
|
|
database
(USA) |
patients
(age 18–84 years) who had ≥1 |
sudden
cardiac death |
Naproxen
= 367 |
Naproxen
= 1409 |
location,
cardiovascular risk score, admission for |
|
|
|
|
prescription
for a COX 2 |
|
|
|
noncardiac-related
|
|
|
|
|
selective
or non- |
|
|
|
disorders
and same-day |
|
|
|
|
selective
NSAID |
|
|
|
procedures,
emergency room visits for |
|
|
|
|
|
|
|
|
noncardiovascular
reasons, |
|
|
|
|
|
|
|
|
HRT,
and high-dose prednisolone |
|
|
Nested
case control QRESEARCH |
Current
NSAID users: |
First
hospitalized |
Ibuprofen
= 460 |
Ibuprofen
= 3199 |
Use
of aspirin, statin, |
||
|
|
(UK)
|
patients
(age 25–100 |
AMI/CHD,
sudden |
Naproxen
= 96 |
Naproxen
= 677 |
tricyclic
antidepressants, |
|
|
|
|
years)
who had a |
death
|
Other
nonselective |
Other
nonselective |
SSRI,
ischemic heart |
|
|
|
|
prescription
for selective |
|
NSAIDs
= 181 |
NSAIDs
= 1266 |
disease,
diabetes, |
|
|
|
|
or
nonselective NSAIDs |
|
|
|
hypertension,
OA, RA, |
|
|
|
|
within
the 3 months |
|
|
|
smoking
obesity, and |
|
|
|
|
before
the index data |
|
|
|
deprivation
|
|
|
Case
control Hospital discharge |
Current
nonaspirin |
First
hospitalized |
Naproxen
= 26 |
Naproxen
= 175 |
Discharge
diagnosis of |
||
|
|
registry
(Denmark) |
NSAID
users: patients |
AMI
|
Other
nonaspirin |
Other
nonaspirin |
CVD,
hypertension, |
|
|
|
|
(age
20–101 years) who |
|
NSAIDs
= 532 |
NSAIDs
= 3105 |
diabetes,
chronic bronchitis |
|
|
|
|
had
received a |
|
|
|
or
emphysema, acholoism, |
|
|
|
|
prescription
within 30 |
|
|
|
liver
cirrhosis, upper GI |
|
|
|
|
days
before the index |
|
|
|
bleed,
RA, systemic lupus |
|
|
|
|
date
|
|
|
|
erythematosus
and use of high-dose aspirin, platelet inhibitors, insulin or oral |
|
|
|
|
|
|
|
|
hypoglycemic
drugs, antihypertensive drugs, lipid-lowering drugs, oral anticoagulants,
hormone therapy, nitrates, penicillamine, gold and glucocorticocoids
before date of admission |
|
|
Nested
case control Administrative health database |
New
NSAID users: patients (age ≥66 years) |
First
Hospitalized AMI |
Naproxen
= 23 Other nonselective, |
Naproxen
= 336 Other nonselective, |
Age,
sex, hypertension, CAD, cerebrovascular |
||
|
|
(Québec,
Canada) |
who
had a dispensed |
|
nonaspirin
NSAIDs |
nonaspirin
NSAIDs |
disease,
peripheral |
|
|
|
|
prescription
with a |
|
=
51 |
=
962 |
vascular
disease, CCF, |
|
|
|
|
duration
that covered or |
|
|
|
statin,
aspirin, |
|
|
|
|
overlapped
with the |
|
|
|
anticoagulants,
presence of |
|
|
|
|
index
date |
|
|
|
respiratory
disease, GI ulcer disease, thyroid disease, depression or psychiatric
illness, use of oral corticosteroids, |
|
|
|
|
|
|
|
|
Chronic
disease score, |
|
|
|
|
|
|
|
|
Charlson
index, health care |
|
|
|
|
|
|
|
|
utilization
|
|
|
Retrospective
cohort Administrative health database |
New
NSAID users: patients (age ≥66 years) |
Hospitalized
AMI |
Naproxen
= 15 Other nonselective, |
Naproxen
= 5654 Other nonselective, |
Hospitalization
in prior year, malignancy in prior 5 years, |
||
|
|
(Ontario,
Canada) |
who
received a |
|
non-naproxen |
nonaspirin NSAIDs
|
MI,
stroke, CAD or CABG |
|
|
|
|||||||